CEPD is an international holding company, which operates the 3rd largest pharmacy chain in the European Union with over 1500 pharmacies in Poland, Lithuania and Sweden.
CEPD is an experienced and knowledgeable healthcare actor in Europe, with a distinctive know-how and solid foundations. The Company was incorporated in the Netherlands in 2008, and has its headquarters in Amsterdam. It is the retail business line of Pelion S.A., the largest company operating in the healthcare sector in Poland.
CEPD has more than 13 years of experience in the retail pharmaceutical market. Company ethos dictates exceptional pharmaceutical care whilst providing extensive experience with e−commerce. With a particular focus on the needs of our patients, we place emphasis on customer service and it remains at the forefront of our values.
Our mission is to care for a healthy and long life of our patients and clients by providing easy access to affordable products and the best advice.
Our vision is to be the European lead for the health and wellbeing of our patients and clients by being flexible and creative while providing world class products and services.
The Management Board of CEPD consists in a board of directors, structured in the form of a one-tier board composed of non-executive and executive directors.
Dr Fritz Oesterle graduated in law at the University of Tübingen and received his doctorate degree in law in 1979. He also completed the Harvard Business School in 1998.
Dr Oesterle was a partner of Gleiss Lutz, an international, Stuttgart-based law firm till 1989. In 1990 he established and managed his own law firm together with Dr Frank Oppenländer (Oppenländer, Oesterle & Partner) till he took over the role as Chairman of the Management Board and Chief Executive Officer of Celesio AG in 1999. He has held this position for more than 12 years till 30th of June 2011.
Dr Fritz Oesterle has more than 20 years of managerial experience in the pharmaceutical sector. In the past, he held – beside his positions in companies of Celesio Group – positions in supervisory boards of several companies from pharmaceutical, financial and other sectors: Dino entertainment AG, Stuttgart, Christophsbad Göppingen, Dr. Landerer Söhne GmbH, Göppingen; Eckert & Ziegler Strahlen- and Medizintechnik AG, Berlin.
He was a member of the Board of Directors of IFPW (International Federation of Pharmaceutical Wholesalers, Inc.), Fairfax, Virginia, and a member of the executive Committee of GIRP (Groupement International de la Repartition Pharmaceutique Européenne), Brussels (European Association of pharmaceutical wholesalers). Dr Oesterle is a member of the Health Committee of DIHK.
Currently Dr Oesterle is one out of 6 trustees of Schwarz Unternehmenstreuhand KG (the holding company of Lidl and Kaufland) and he holds the following positions in Supervisory and Advisory Boards: Member of the Advisory Board of Société Générale in Germany;member of the Supervisory Board of Landesbank Baden-Württemberg (LBBW); Chairman of the Supervisory Board of Untertürkheimer Volksbank eG; Chairman of the Advisory Board of Schmieder Kliniken, Allensbach, the leading hospital chain for neurological rehabilitation in Germany.
Since 2006 Dr Fritz Oesterle serves as British Honorary Consul in Baden-Württemberg.
Entrepreneur, co-founder and the President of the Management Board of Pelion S.A..
Mr Jacek Szwajcowski holds a degree from the Faculty of Mechanical Engineering of the Technical University of Łódź.
Jacek Szwajcowski is a co-founder of Pelion S.A., where he serves as a Chief Executive Officer from the beginning of the company’s founding. The company was established in 1990 on the initiative of a group of Polish entrepreneurs. Ever since Pelion has been an important contributor to Poland’s economy, active across all segments of pharmaceutical distribution: wholesale, retail sales and sales to hospitals, and expanding its foothold in Lithuania and Sweden. The company's mission is to care for the quality and length of life.
In addition to involvement in the further development of the company, Jacek engages in the Polish Business Roundtable, an organization associating owners and key managers of the largest Polish enterprises, and companies operating in Poland, serving as a President of the association until May 2019 and currently being its Member.
As a part of postgraduate education, he completed courses at Harvard Kennedy School, George Mason University, Said Business School – University of Oxford and Jackson Institute for Global Affairs – Yale University. He is a member of the Supervisory Board of several companies, including listed company Pharmena S.A.
Initiator of the "I care for my health" Foundation, assisting the elderly to obtain essential medicines. As a passionate of the tradition of Polish pharmacy, he initiated the Museum of Pharmacy in Lodz. Publisher of series of monographs about the most famous Polish pharmacies.
Vice-President of the Management Board of Pelion S.A., responsible for Distribution.
Mr Zbigniew Molenda holds a degree from the Faculty of Electrical Engineering of the Technical University of Łódź.
In 1990, Mr Zbigniew Molenda co-founded Hurtownia Leków MEDICINES (a wholesale pharmaceutical outlet), in which, upon its transformation into a joint-stock company, he assumed the position of Vice-President of the Management Board. The company is still operating, currently as a holding company under the name of Pelion S.A., Mr Zbigniew Molenda has remained Vice-President of the Management Board of Pelion S.A, which has been active in the healthcare sector for many years now.
Vice-President of the Management Board of Pelion S.A., responsible for Finance.
Mr Jacek Dauenhauer holds a degree from the Faculty of Economics of the University of Łódź. He has also completed a number of courses and training programmes in economics and finance, including a course for investment advisers in 1993.
From 1997, Mr Dauenhauer worked for Medicines S.A., and then for Polska Grupa Farmaceutyczna S.A., where he was Chief Financial Officer, and since 2007 served as Vice-President of the Management Board. Currently, Mr Dauenhauer is Vice-President of the Management Board of the holding company, Pelion S.A. (formerly: PGF S.A.).
Alicja Koleśnik graduated from the Faculty of Management at the University of Economics in Poznan. She also completed MBA and Executive MBA studies at the Canadian Management Institute and many foreign management and marketing programmes at Harvard Business School, The Kellogg School of Management, as well as at INSEAD Business School incl. Advanced Management Programme.
Alicja Koleśnik's professional experience is related to the retail market. Before joining the DOZ Team, for eighteen years she successfully managed the commercial area in the international retail chain Jeronimo Martins Group, which is the undisputed leader in its market.
Alicja Koleśnik has been associated with Pelion since January 2015. As the Chairman of the Management Board of DOZ S.A. she successfully and effectively implemented the restructuring of the company, setting out the strategy and directions of development for the following years.
She strengthened the position of DOZ S.A. in the retail pharmaceutical market, consistently achieving its goals and implementing modern solutions for Patients. By introducing innovative concepts and high standards, she took care to create a friendly reality for Patients, Employees and Business Partners.
DOZ S.A. has received four times in a row (in 2017-2020) the prestigious title of Best Workplace in Poland, awarded by the international Great Place to Work institute to companies operating on the basis of trust and ensuring the satisfaction of employees. In 2020, the Polish Business Council awarded DOZ S.A. the Retail Business Award in the Market Innovator category.
Ms Egle Zulaniene is a graduate of the Lithuanian University of Health Sciences in Kaunas with followed residency of otorhinolaryngology and doctor’s practise at university’s hospital in Kaunas.
Ms Egle Zulaniene has also graduated International School of Management (Executive MBA), Academy of Psychology (Vilnius).
She was the owner of Lithuanian wholesale and retail vertically integrated pharmaceutical distributing companies in Lithuania, after sale of business to Pelion Healthcare Group Ms Egle Zulaniene has been serving as a Chairperson of Management board at Nacionalinė Farmacijos Grupė, branch of Pelion Healthcare Group in Lithuania.
Vice-President of the Management Board of Pelion S.A., responsible for Development and Strategic Projects.
Ms Mariola Belina-Prażmowska is a graduate of the University of Lodz’s Faculty of Economics and Sociology, where her principal field of study was International Economic and Political Relations.
In 2005, she was certified as a Statutory Auditor. Ms Belina-Prażmowska developed her professional career working at Deloitte Audyt Sp. z o.o., where she advanced from the position of assistant to manager. She then became Finance Director at Clear Edge Polska Sp. z o.o. and Thunderbird Resort Poland Sp. z o.o. (an investment fund).
She has been associated with Pelion company since 2009. She co-organized the subsidiary of Pelion S.A., Business Support Solution S.A. and in 2010 - 2013 performed there the Vice President and then the President of the Management Board position.
From January 2014, she has occupied in Pelion S.A. a position of Vice-President of the Management Board responsible at first for Development and Investor Relations. At present her field of activity is Business Development and Expansion of Innovative Projects implemented by the company. She is the expert of innovative projects and start’ups and participant in many conferences dedicated this theme.
As the member of Pelion Management Board Ms Belina - Prażmowska is in charge of supervising strategic areas and start’ups projects. She holds the positions in Supervisory Boards of: Polska Grupa Farmaceutyczna S.A., DOZ S.A., Business Support Solution S.A., Intelligent Logistic Solutions Sp. z o.o. and Dimedic Polska, UAB Dimedic Baltic, Animal Care S.A..
She also is a member of Management Board of UAB – the Lithuanian subsidiary of Pelion S.A., takes a position of Non- Executive Director of CEPD N.V. associated with Pelion Group and a member of the Review Commission of the „Marathon Dbam o Zdrowie” Association.
Mrs. Karine Poindessault graduated from the University of Rennes, France where she completed her Master’s Degree in business and corporate law in 1995.
She did a one year Erasmus program at the University of Utrecht, the Netherlands, and is holder of a postgraduate degree “Law, Economics and Project Management with Eastern European Countries”, from the University of Aix-Marseille III, France. She has completed a number of courses and training programs in company law under Dutch law.
Mrs. Karine Poindessault has 20 years of experience in the Netherlands as in-house corporate lawyer, and worked for the Larmag Group, New Amsterdam Cititrust B.V. and EQT/CBTJ Financial Services B.V..
Mrs. Karine Poindessault joined CEPD N.V. and set-up the office of the company in 2011. She has been responsible for the operations in Amsterdam since then, as well as for inter-alia the company’s corporate governance.
She speaks French, Dutch and English fluently and has worked in the Spanish language.
President of the Royal Tropical Institute (KIT) in the Netherlands.
Mr Mark Schneiders completed his Bachelor and Master’s degree in law from the University of Leiden, the Netherlands, and Advanced Management Program at Harvard Business School and banking management programs at INSEAD.
Mr Mark Schneiders has more than 30 years of managerial experience in the banking sector. He has extensive experience in company mergers, building new markets and setting up retail bank businesses in a variety of countries including Switzerland, the Netherlands, Spain, Curaçao, Argentina, Venezuela, Hong Kong and New York.
Mr Mark Schneiders served as a Managing Director of ING Financial Institutions in Amsterdam (2004-2007), as a General Manager and Head of Dutch Business at ING Bank Switzerland ( 2001-2004), and as a Country Manager for ING Barings in Venezuela and Curacao (1992-2001). He also held the position of Managing director at ADC African Development Corporation (2010-2014). Apart from being a non-executive director of CEPD NV, he is also a non-executive director of BancABCHolding in Botswana. On June 1st, 2014 he was appointed as KIT’s CEO.
Tomas is a financial professional with 25 years of experience in various financial activities featuring treasury, investment appraisal, mergers & acquisitions as well as risk management. He used to be a CFO for almost 19 years at the largest agribusiness holdings in Baltics, and acted as a CFO at JSC Limedika (Pelion Group) and a Board Member of JSC Nacionaline Farmacijos Kompanija (National Pharmacy Company). During his career he implemented various long and short term financing projects worth up to 350 mln Euro, including bonds issues and IPO process.
In addition to his professional work, Tomas has a solid experience in acting as an independent board member both in private and State Owned Enterprises.
Tomas holds an MSc degree in Economics at Vilnius University and an MBA in finance at Manchester Business School. In 2016 he was elected as a CFO of the YEAR in Lithuania.